泌尿肿瘤-医药代表-广州

阿斯利康投资（中国）有限公司

Chinese investment and holding company of AstraZeneca, the British-Swedish biopharmaceutical group headquartered in Cambridge. Oversees the group's Chinese business from its Shanghai headquarters, covering manufacturing sites in Wuxi, Taizhou and Qingdao, research and development and clinical operations, and the marketing of medicines in oncology, cardiovascular, renal and metabolic disease, respiratory and immunology and rare disease, together with regional headquarters and life science innovation hubs across China.